WC
DGX icon

Waterloo Capital’s Quest Diagnostics DGX Stock Holding History

Waterloo Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.65M Buy
26,666
+1,847
+7% +$362K 0.32% 74
2026
Q1 		$4.86M Sell
24,819
-1,511
-6% -$294K 0.34% 70
2025
Q4 		$4.57M Buy
26,330
+551
+2% +$100K 0.33% 72
2025
Q3 		$4.91M Buy
25,779
+3,499
+16% +$621K 0.37% 63
2025
Q2 		$4M Buy
22,280
+1,935
+10% +$336K 0.32% 72
2025
Q1 		$3.44M Buy
20,345
+2,997
+17% +$492K 0.32% 84
2024
Q4 		$2.62M Buy
17,348
+1,528
+10% +$238K 0.28% 92
2024
Q3 		$2.46M Buy
15,820
+11,423
+260% +$1.71M 0.27% 94
2024
Q2 		$602K Buy
4,397
+255
+6% +$34.9K 0.07% 200
2024
Q1 		$551K Sell
4,142
-1,271
-23% -$165K 0.07% 210
2023
Q4 		$746K Buy
+5,413
New +$712K 0.12% 165

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Waterloo Capital's DGX Position: Q2 2026 in Review

Waterloo Capital increased its Quest Diagnostics (DGX) stake by 7.4% in Q2 2026, buying an estimated $362K and bringing the position to 26,666 shares worth $5.65M. The position accounts for 0.32% of the portfolio, ranked #74.

Waterloo Capital first reported a position in DGX in Q4 2023 and has held it in 11 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Waterloo Capital held 26,666 shares of Quest Diagnostics worth $5.65M as of Q2 2026.
  • Waterloo Capital bought 1,847 Quest Diagnostics shares in Q2 2026, an estimated $362K.
  • Quest Diagnostics made up 0.32% of Waterloo Capital's portfolio in Q2 2026, its #74 holding.
  • Waterloo Capital first reported a position in Quest Diagnostics in Q4 2023 and has held it in 11 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Waterloo Capital's 13F filing for Q2 2026, filed 29 Jul 2026.